Multiple courses of antenatal corticosteroids for preterm Birth study outcomes in children at 5 years of age (MACS-5)

JAMA Pediatrics

Volumn 167, Issue 12, 2013, Pages 1102-1110

  Asztalos, Elizabeth V ^a,h   Murphy, Kellie E ^b   Willan, Andrew R ^a   Matthews, Stephen G ^a   Ohlsson, Arne ^a   Saigal, Saroj ^c   Armson, B Anthony ^d   Kelly, Edmond N ^a   Delisle, Marie France ^e   Gafni, Amiram ^f   Lee, Shoo K ^a   Sananes, Renee ^g   Rovet, Joanne ^g   Guselle, Patricia ^g   Amankwah, Kofi ^a   Saleem, Mariam ^a   Sanchez, Johanna ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h Sunnybrook Health Sciences Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; ATTENTION; BEHAVIOR; BLINDNESS; BLOOD PRESSURE; BODY HEIGHT; BODY WEIGHT; CEREBRAL PALSY; CHILD; CHILDHOOD MORTALITY; CORTICOSTEROID THERAPY; DEATH; DEVELOPMENTAL DISORDER; FEMALE; FETUS; FOLLOW UP; HEAD CIRCUMFERENCE; HEARING AID; HEARING IMPAIRMENT; HUMAN; INFANT; INTELLIGENCE; LANGUAGE; MAJOR CLINICAL STUDY; MEMORY; PREMATURE LABOR; PRENATAL CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; SURVIVAL; VISION; VISUAL AID;

ABNORMALITIES, DRUG-INDUCED; ADULT; BETAMETHASONE; CHILD BEHAVIOR DISORDERS; CHILD, PRESCHOOL; COHORT STUDIES; DEVELOPMENTAL DISABILITIES; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INJECTIONS, INTRAMUSCULAR; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84890091564     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2013.2764     Document Type: Article

References (36)

1. Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162-2172.
2. Schmidt B, Asztalos EV, Roberts RS, Robertson CM, Sauve RS, Whitfield MF; Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA. 2003;289(9):1124-1129.
3. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement. 1994;12(2):1-24.
4. Crane J, Armson A, Brunner M, et al; Executive Committee of the Society of Obstetricians and Gynaecologists of Canada. Antenatal corticosteroid therapy for fetal maturation. J Obstet Gynaecol Can. 2003;25(1):45-52.
5. McLaughlin KJ, Crowther CA,Walker N, Harding JE. Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review. AustNZJObstet Gynaecol. 2003;43(2):101-106.
6. Murphy KE, Hannah ME,Willan AR, et al;MACS Collaborative Group. Multiple Courses of Antenatal Corticosteroids for Preterm Birth (MACS): a randomised controlled trial. Lancet. 2008;372(9656):2143-2151.
7. Murphy KE, Willan AR, Hannah ME, et al; Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study Collaborative Group. Effect of antenatal corticosteroids on fetal growth and gestational age at birth. Obstet Gynecol. 2012;119(5):917-923.
8. Asztalos EV, Murphy KE, Hannah ME, et al; Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study Collaborative Group. Multiple Courses of Antenatal Corticosteroids for Preterm Birth Study: 2-year outcomes. Pediatrics. 2010;126(5):e1045-e1055.
9. Crowther CA, Doyle LW, Haslam RR, Hiller JE, Harding JE, Robinson JS; ACTORDS Study Group. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357(12):1179-1189.
10. Wapner RJ, Sorokin Y, Mele L, et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357(12): 1190-1198.
11. Peltoniemi OM, Kari MA, Lano A, et al; Repeat Antenatal Betamethasone (RepeatBM) Follow-Up Study Group. Two-year follow-up of a randomized trial with repeated antenatal betamethasone. Arch Dis Child Fetal Neonatal Ed. 2009;94(6):F402-F406.
12. Dunlop SA, Archer MA, Quinlivan JA, Beazley LD, Newnham JP. Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J Matern Fetal Med. 1997;6(6):309-313.
13. HuangWL, Harper CG, Evans SF, Newnham JP, Dunlop SA. Repeated prenatal corticosteroid administration delaysmyelination of the corpus callosum in fetal sheep. Int J Dev Neurosci. 2001;19(4):415-425.
14. Uno H, Lohmiller L, Thieme C, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques, I: hippocampus. Brain Res Dev Brain Res.1990;53(2):157-167.
15. Halliday HL, Ehrenkranz RA, Doyle LW. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2010;1(1):CD001146.
16. Palisano R, Rosenbaum P,Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol.1997;39(4):214-223.
17. Gioia GA, Isquith PK, Guy PK, Kenworthy L. Behavior Rating Inventory of Executive Function (BRIEF). Odessa, FL: Psychological Assessment Resources; 2000.
18. Achenbach TM. Manual for the Child Behavior Checklist: 1 1/2-5 Years. Burlington: University of Vermont; 2002.
19. Wechsler D.Wechsler Preschool and Primary Scale of Intelligence: 3rd Edition (WPPSI-III). San Antonio, TX: The Psychological Corporation; 2002.
20. Beery KE. The Developmental Test of Visual-Motor Integration. 5th ed. Parsippany, NJ: Modern Curriculum Press; 2004.
21. Dunn LM, Dunn DM. Peabody Picture Vocabulary Test: 3rd Edition (PPVT-III). Circle Pines, MN: American Guidance Service; 1997.
22. Crowley P. WITHDRAWN: prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev. 2006;(3):CD000065.
23. World Health Organization. Neonatal and perinatal mortality: country, regional and global estimates. http://www.who.int/maternal child adolescent/documents/9241563206/en/.Accessed March 1, 2007.
24. Crowther CA, McKinlay CJ,Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2011;6(6):CD003935.
25. McKinlay CJ, Crowther CA,Middleton P, Harding JE. Repeat antenatal glucocorticoids for women at risk of preterm birth: a Cochrane systematic review. Am J Obstet Gynecol. 2012;206(3):187-194.
26. French NP, Hagan R, Evans SF, Mullan A, Newnham JP. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol. 2004;190(3):588-595.
27. Beitins IZ, Bayard F, Ances IG, Kowarski A, Migeon CJ. The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr Res. 1973;7(5):509-519.
28. Lopez Bernal A, Craft IL. Corticosteroid metabolism in vitro by human placenta, fetal membranes and decidua in early and late gestation. Placenta. 1981;2(4):279-285.
29. ChurchMW,Wapner RJ, Mele LM, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Repeated courses of antenatal corticosteroids: are there effects on the infant'
30. Amin SB, Guillet R. Auditory neural maturation after exposure to multiple courses of antenatal betamethasone in premature infants as evaluated by auditory brainstem response. Pediatrics. 2007;119(3):502-508.
31. Barker DJ. The origins of the developmental origins theory. J Intern Med. 2007;261(5):412-417.
32. Waterland RA,Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr. 2007;27:363-388.
33. Crudo A, Petropoulos S, Moisiadis VG, et al. Prenatal synthetic glucocorticoid treatment changes DNA methylation states in male organ systems: multigenerational effects. Endocrinology. 2012;153(7):3269-3283.
34. Kapoor A, Petropoulos S, Matthews SG. Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids. Brain Res Rev. 2008;57(2):586-595.
35. Thomassin H, FlavinM, Espinas ML, Grange T. Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J. 2001;20(8):1974-1983.
36. SzyfM. Early life, the epigenome and human health. Acta Paediatr. 2009;98(7):1082-1084.